2 Jefferies Group Axsome Therapeutics Trades
Jefferies Group's position in Axsome Therapeutics is currently worth $40.8 Million. That's 0.65% of their equity portfolio (17th largest holding). The investor owns 1.17% of the outstanding Axsome Therapeutics stock. The investor's estimated purchase price is $42 Million, resulting in a loss of 2.8%.
News about Axsome Therapeutics Inc and Jefferies Group
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against First High-School, Upstart, Oscar Health, and Axsome and Encourages Investors to Contact the Firm
NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class ac...
Goldman Sachs Group Inc. Has $2.84 Million Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Goldman Sachs Group Inc. lowered its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) by 70.5% during the second quarter, according to its most recent Form 1...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Sold by Man Group plc
Man Group plc trimmed its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) by 80.9% during the second quarter, Holdings Channel reports. The fir...